These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3407318)

  • 21. Platelet malondialdehyde and plasma thromboxane B2 formation in patients with obliterative arteriosclerosis of the lower limbs.
    Bodzenta A; Bielawiec M; Krupiński K; Wojtukiewicz M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(5):804-7. PubMed ID: 6188668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prostaglandin E1 in therapy of peripheral arterial occlusive disease].
    Sinzinger H; Rogatti W
    Wien Klin Wochenschr; 1991; 103(18):558-65. PubMed ID: 1750223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Venous prostacycline synthesis and plasma thromboxane B2 after low-dose aspirin].
    Kaliman J; Cromwell M; Sinzinger H
    Wien Klin Wochenschr; 1983 Sep; 95(17):615-7. PubMed ID: 6359724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acetylsalicylic acid in arterial circulatory disorders. Which dosage in which indication?].
    Ranke C; Creutzig A; Alexander K
    Dtsch Med Wochenschr; 1994 Jun; 119(22):815-21. PubMed ID: 8205945
    [No Abstract]   [Full Text] [Related]  

  • 25. Platelet survival and serotonin content after placement of arterial prostheses in dogs: effects of neointimal coverage and high- and low-dose aspirin.
    Clagett GP; Hufnagel H; Watkins MT; Sharefkin JB
    J Vasc Surg; 1987 Dec; 6(6):555-62. PubMed ID: 3320388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet malondialdehyde in cardiovascular disease: effect of prosthetic heart valves and cardioactive drugs on production.
    Sullivan JM; Taylor JC; Samaha JK
    Thromb Haemost; 1980 Oct; 44(2):76-80. PubMed ID: 7455995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events. A critical analysis.
    Stalnikowicz-Darvasi R
    J Clin Gastroenterol; 1995 Jul; 21(1):13-6. PubMed ID: 7560825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between hyperhomocysteinemia and endothelial activation in patients with obliterative arteriopathy of the legs].
    Rogolino A; Farsi A; Brunelli T; Ilari I; Capanni M; Domeneghetti MP; Dorigo W; Lombardi R; Pulli R; Pratesi C; Gensini GF
    Minerva Cardioangiol; 1999 Dec; 47(12):583. PubMed ID: 10670214
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of temperature and preservation time on the aggregation and MDA level of blood platelets].
    Stachecki B; Kaszkowiak M; Kotelba-Witkowska B; Jakuboszczak E; Fenrych W
    Acta Haematol Pol; 1986; 17(3-4):122-30. PubMed ID: 3591238
    [No Abstract]   [Full Text] [Related]  

  • 30. [Formation of platelet malondialdehyde in hypertensive patients subjected to cycloergometric exercise tests].
    Davì G; Novo S; Riolo F; Pinto A; Mendola G; Mazzola A; Fazio M
    Boll Soc Ital Cardiol; 1980; 25(10):1167-72. PubMed ID: 7326120
    [No Abstract]   [Full Text] [Related]  

  • 31. [Application of a method of determining the concentration of malondialdehyde in the formed elements of the blood to predicting the course of ophthalmoherpes].
    Dalgat LD; Kasavina BS; Maĭchuk IuF
    Oftalmol Zh; 1981; 36(8):489-90. PubMed ID: 7335282
    [No Abstract]   [Full Text] [Related]  

  • 32. The basis for aspirin dosage in stroke prevention.
    Brandon RA; Eadie MJ
    Clin Exp Neurol; 1987; 23():47-54. PubMed ID: 3665179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells.
    Mehta JL; Chen J; Yu F; Li DY
    Cardiovasc Res; 2004 Nov; 64(2):243-9. PubMed ID: 15485683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease.
    Buring JE; Hennekens CH
    Am J Gastroenterol; 1991 Sep; 86(9):1279-80. PubMed ID: 1882816
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombogenic and vasoactive effects of smoking--with special reference to peripheral arterial occlusive disease.
    Lassila R
    Ann Chir Gynaecol; 1992; 81(2):107-9. PubMed ID: 1622060
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation.
    Bakhti A; Vaiman D
    Hypertens Res; 2011 Oct; 34(10):1116-20. PubMed ID: 21881579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum malanodialdehyde (TBA reactive substance) levels in cigarette smokers.
    Nadiger HA; Mathew CA; Sadasivudu B
    Atherosclerosis; 1987 Mar; 64(1):71-3. PubMed ID: 3593463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oxygen consumption, release reaction and formation of malondialdehyde in the platelets of newborn infants following addition of thrombin].
    Del Principe D; Damiano AM; Mastracchio F; Corrado G; Menichelli A; Negrini R
    Minerva Pediatr; 1978 Jul; 30(14):1153-6. PubMed ID: 672858
    [No Abstract]   [Full Text] [Related]  

  • 39. [Method of studying lipid peroxidation].
    Goncharenko MS; Latinova AM
    Lab Delo; 1985; (1):60-1. PubMed ID: 2579285
    [No Abstract]   [Full Text] [Related]  

  • 40. [Level of platelet malonaldehyde in diabetics].
    Stoltz JF; Voisin P; Genisti G; Drouin P; Pointel JP; Vernhes G
    Nouv Presse Med; 1980 Jan; 9(4):250. PubMed ID: 7383888
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.